Pipenzolate

DB13844InvestigationalSmall molecule

Pipenzolate is an antimuscarinic agent indicated in the treatment of gastrointestinal motility disorders and arrhythmia. A medication used to treat unusual contractions of the digestive tract and irregular heart beat.

Chemical structure of Pipenzolate
Formula / weight
C22H28NO3 · 354.469 g/mol (avg)

Resolves to

Compound
UNIIRS3K5YXV34CAS13473-38-6ChEMBLCHEMBL1619528ChEBI95178
Clinical / RWD
RxNorm33743ATCA03AB14ATCA03CA09
Structure
InChIKeyWPUKUEMZZRVAKZ-UHFFFAOYSA-NSMILESCC[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1

What you can answer from here — as of August 30, 2026

516Drug interactionsStructured to mechanism, not free text
Sign in
25Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
24ContraindicationsEach with its own population and attribute set
Sign in
6Marketed productsAcross 1 country and 3 labellers
Sign in
2ATC codesIncluding every combination product, plus 6 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Pipenzolate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In